BOTOTLSJU
TNDM icon

Board of Trustees of The Leland Stanford Junior University’s Tandem Diabetes Care TNDM Stock Holding History

Board of Trustees of The Leland Stanford Junior University’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,781
Closed -$323K – 28
2018
Q3 		$323K Buy
+6,781
New +$237K 0.04% 13

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University's TNDM Position: Q4 2018 in Review

Board of Trustees of The Leland Stanford Junior University sold out of Tandem Diabetes Care (TNDM) in Q4 2018, closing a stake of 6,781 shares — an estimated $323K sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in TNDM in Q3 2018 and held it in 1 quarter. The position peaked at $323K in Q3 2018. 200 funds tracked by Wall St. Rank hold TNDM as of Q4 2018.

  • Board of Trustees of The Leland Stanford Junior University reported no remaining Tandem Diabetes Care position as of Q4 2018 after selling out during the quarter.
  • Board of Trustees of The Leland Stanford Junior University sold 6,781 Tandem Diabetes Care shares in Q4 2018, an estimated $323K.
  • Board of Trustees of The Leland Stanford Junior University first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 1 quarter.
  • Board of Trustees of The Leland Stanford Junior University's Tandem Diabetes Care position peaked at $323K in Q3 2018.
  • 200 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2018.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q4 2018, filed 12 Feb 2019.